Given the labyrinth of patent litigation ongoing between companies that were working on mRNA vaccines during the pandemic, a merger agreement between two of them – BioNTech and CureVac ...

BIO 2025 brings pharma, biotech, and policy leaders together to tackle industry challenges. Follow our coverage on AI, vaccines, cell & gene therapy, and key discussions from health officials.

Robin Walsh takes a look back at the origins of the industry in the 19th century and its ongoing evolution ...

Lila Sciences has emerged with $200m in seed financing to advance its vision of AI-powered, fully autonomous labs to power scientific advances ...

Dr Sam Roberts, NICE chief executive, said AstraZeneca and Daiichi Sankyo had not offered a fair price for the drug Discussions aimed at making AstraZeneca and Daiichi Sankyo's Enhertu available ...

Jury awards $750m in punitive damages against J&J in a case brought by four people claiming they developed cancer after using talc products; judge reduces sum to $187mm as J&J plans appeal ...

FDA has approved Vertex and CRISPR Therapeutics' Casgevy as first CRISPR based therapy for transfusion-dependent thalassaemia.

Valneva has been awarded $41m in funding from the CEPI and EU to expand access to its recently approved Ixchiq vaccine for chikungunya virus.

Regulatory agencies are offering more flexibility when it comes to viral clearance strategies, but this must be aligned with ...

In another sign of increased regulatory scrutiny of vaccines in the US, Health and Human Services (HHS) Secretary Robert F ...

Precigen has won approval in the US for a first-in-class immunotherapy for recurrent respiratory papillomatosis (RRP), a rare ...

The executive order from President Donald Trump calls on the HHS' Office of the Assistant Secretary for Preparedness and ...